Assessment of Longer-Term Efficacy and Safety in the Phase 3, Randomized, Double-Blind, Placebo-Controlled MEDALIST Trial of Luspatercept to Treat Anemia in Patients (Pts) with Revised International Prognostic Scoring System (IPSS-R) Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes ( MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

Fenaux P., Mufti G. J., Buckstein R., Santini V., Diez-Campelo M., Finelli C., ...More

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 7 - 10 December 2019, vol.134, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 134
  • Doi Number: 10.1182/blood-2019-123064
  • City: Florida
  • Country: United States Of America
  • Ankara University Affiliated: Yes